Kai-Oliver Henrich Selected Research

Kai-Oliver Henrich Research Topics

21	Neuroblastoma 01/2022 - 01/2006
13	Neoplasms (Cancer) 12/2022 - 08/2007
2	Melanoma (Melanoma, Malignant) 09/2016 - 07/2016
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022
1	Noncommunicable Diseases 06/2019
1	Colorectal Neoplasms (Colorectal Cancer) 09/2016
1	Hepatocellular Carcinoma (Hepatoma) 07/2016
1	Lymphoma (Lymphomas) 07/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2016
1	Spontaneous Remission 01/2016
1	Disease Progression 10/2015
1	Dementia (Dementias) 12/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2008

8	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2007
6	Messenger RNA (mRNA)IBA 10/2021 - 08/2007
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2016 - 04/2011
2	ProteomeIBA 12/2022 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 02/2016
2	N-Myc Proto-Oncogene ProteinIBA 10/2021 - 05/2010
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021 - 10/2015
2	ChromatinIBA 07/2016 - 10/2008
2	Decitabine FDA Link 02/2016 - 12/2014
2	Complementary DNA (cDNA)IBA 08/2007 - 01/2006
1	venetoclaxIBA 12/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	Cystine (L-Cystine)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 11/2020
1	MicroRNAs (MicroRNA)IBA 06/2019
1	Histone Deacetylase InhibitorsIBA 01/2019
1	CateninsIBA 09/2016
1	LuciferasesIBA 07/2016
1	LigandsIBA 07/2016
1	Small Interfering RNA (siRNA)IBA 07/2016
1	Tetracycline (Achromycin)FDA LinkGeneric 02/2016
1	Histones (Histone)IBA 01/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2015
1	DNA (Deoxyribonucleic Acid)IBA 12/2014
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 04/2011
1	Protein Isoforms (Isoforms)IBA 11/2009
1	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 12/2008
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2008
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 08/2007
1	F-Box ProteinsIBA 08/2007

7	Therapeutics 12/2022 - 01/2016
1	Drug Therapy (Chemotherapy) 12/2022
1	Combination Drug Therapy (Combination Chemotherapy) 12/2022
1	Immunotherapy 07/2016
1	Combined Modality Therapy 10/2015